Yu Zeng

812 total citations
37 papers, 580 citations indexed

About

Yu Zeng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu Zeng has authored 37 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Yu Zeng's work include Circular RNAs in diseases (7 papers), RNA Research and Splicing (7 papers) and Cancer-related gene regulation (6 papers). Yu Zeng is often cited by papers focused on Circular RNAs in diseases (7 papers), RNA Research and Splicing (7 papers) and Cancer-related gene regulation (6 papers). Yu Zeng collaborates with scholars based in China, United States and Canada. Yu Zeng's co-authors include Ye Song, Steven R. Tannenbaum, Zhixiong Liu, Zhiyong Wu, Anqi Xu, Xizhao Wang, Erin G. Prestwich, Wenjie Ye, Arkadiusz R. Raczynski and Rosa G. Liberman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Yu Zeng

37 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Zeng China 14 390 149 93 82 67 37 580
Anna Paczulla Germany 8 297 0.8× 96 0.6× 71 0.8× 152 1.9× 42 0.6× 13 550
Jianming Wang China 16 355 0.9× 190 1.3× 121 1.3× 193 2.4× 95 1.4× 39 708
Maja Milanovic Germany 12 403 1.0× 116 0.8× 171 1.8× 124 1.5× 28 0.4× 21 646
Andrea Martello Italy 17 395 1.0× 141 0.9× 71 0.8× 84 1.0× 34 0.5× 24 634
Carmen M. Anadon United States 10 334 0.9× 141 0.9× 187 2.0× 195 2.4× 48 0.7× 18 634
Klaus Fortschegger Austria 13 569 1.5× 204 1.4× 92 1.0× 58 0.7× 23 0.3× 18 780
Meimei Wan United States 16 659 1.7× 306 2.1× 66 0.7× 117 1.4× 68 1.0× 21 915
Mark Badeaux United States 11 376 1.0× 121 0.8× 56 0.6× 236 2.9× 110 1.6× 15 608
Xiangsheng Yang China 14 345 0.9× 146 1.0× 61 0.7× 51 0.6× 43 0.6× 25 526

Countries citing papers authored by Yu Zeng

Since Specialization
Citations

This map shows the geographic impact of Yu Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Zeng more than expected).

Fields of papers citing papers by Yu Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Zeng. The network helps show where Yu Zeng may publish in the future.

Co-authorship network of co-authors of Yu Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Zeng. A scholar is included among the top collaborators of Yu Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Zeng. Yu Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Xue, Bing Xiu, Muye Yang, et al.. (2025). Ubiquitin-specific protease 7-mediated stabilization of discoidin domain receptor 1 drives progression of TP53-Mutant cancers. Journal of Biological Chemistry. 301(9). 110515–110515. 1 indexed citations
3.
Man, Baoyuan, Yu Zeng, Qingrui Liu, et al.. (2025). A Comprehensive Review of Sulfide Solid-State Electrolytes: Properties, Synthesis, Applications, and Challenges. Crystals. 15(6). 492–492. 4 indexed citations
4.
Yu, Meilan, et al.. (2024). LRP11-AS1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal Cancer via the miR-149-3p/CDK4 pathway. Cancer Gene Therapy. 32(2). 184–197. 3 indexed citations
5.
Zeng, Yu, Li Wang, Yuxin Xie, et al.. (2023). SEC61G assists EGFR -amplified glioblastoma to evade immune elimination. Proceedings of the National Academy of Sciences. 120(32). e2303400120–e2303400120. 13 indexed citations
6.
Zhu, Jinyong, Zhen Liu, Yu Zeng, et al.. (2023). Genome-wide identification of potato (Solanum tuberosum L.) PAL gene family and its expression analysis in abiotic stress and tuber anthocyanin synthesis. ACTA AGRONOMICA SINICA. 49(11). 2978–2990. 1 indexed citations
8.
Han, Zelong, Yuxin Xie, Yanwen Chen, et al.. (2022). Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis. Cell Death Discovery. 8(1). 445–445. 10 indexed citations
9.
Zhang, Peidong, Zhihao Li, Peiliang Chen, et al.. (2022). Regular proton pump inhibitor use and incident dementia: population-based cohort study. BMC Medicine. 20(1). 271–271. 12 indexed citations
10.
Zeng, Yu, Jiqin Zhang, Weijia Liu, et al.. (2022). The Role of DACT Family Members in Tumorigenesis and Tumor Progression. International Journal of Biological Sciences. 18(11). 4532–4544. 5 indexed citations
11.
Lin, Jie, Wei Xu, Yu Zeng, et al.. (2022). Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response. Frontiers in Immunology. 13. 910490–910490. 10 indexed citations
12.
Zhang, Lihua, Zhen Zou, Yanli Lei, et al.. (2021). Bidirectional modulation of microRNA with a clamp-like triplex switch for enhanced and programmed gene therapy. Chemical Communications. 57(91). 12131–12134. 1 indexed citations
13.
Zeng, Yu, et al.. (2021). Current Advances and Challenges in Radiomics of Brain Tumors. Frontiers in Oncology. 11. 732196–732196. 36 indexed citations
14.
Zeng, Yu, Tianshi Que, Jie Lin, et al.. (2021). Oncogenic ZEB2/miR-637/HMGA1 signaling axis targeting vimentin promotes the malignant phenotype of glioma. Molecular Therapy — Nucleic Acids. 23. 769–782. 18 indexed citations
15.
Xu, Anqi, Xizhao Wang, Jie Luo, et al.. (2021). Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating β-catenin. Cell Death and Disease. 12(2). 157–157. 18 indexed citations
16.
Wu, Zhiyong, Jie Luo, Anqi Xu, et al.. (2020). MiR-4310 induced by SP1 targets PTEN to promote glioma progression. Cancer Cell International. 20(1). 567–567. 12 indexed citations
17.
Lin, Jie, Zhiyong Wu, Jie Luo, et al.. (2020). MicroRNA-4476 promotes glioma progression through a miR-4476/APC/β-catenin/c-Jun positive feedback loop. Cell Death and Disease. 11(4). 269–269. 18 indexed citations
18.
Wang, Xizhao, Yu Zeng, Xian Zhang, et al.. (2019). SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways. Cancer Cell International. 19(1). 324–324. 14 indexed citations
19.
Wu, Yan, Lu Wang, Ping Zhou, et al.. (2011). Regulation of REGγ cellular distribution and function by SUMO modification. Cell Research. 21(5). 807–816. 26 indexed citations
20.
McBee, Megan E., Yu Zeng, N. Parry, et al.. (2010). Multivariate Modeling Identifies Neutrophil- and Th17-Related Factors as Differential Serum Biomarkers of Chronic Murine Colitis. PLoS ONE. 5(10). e13277–e13277. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026